|
MechanismAT III activators |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date07 Dec 2001 |
|
MechanismBacterial DNA gyrase inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Glaxo Wellcome Production SAS
0 Patents (Medical) associated with Glaxo Wellcome Production SAS
100 Deals associated with Glaxo Wellcome Production SAS
100 Translational Medicine associated with Glaxo Wellcome Production SAS